Trametinib: New Go-To for Low-Grade Serous Ovarian Carcinoma? Trametinib: New Go-To for Low-Grade Serous Ovarian Carcinoma?

For the first time, a randomized trial has reported positive results in patients with this particular type of ovarian cancer.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news